Publication | Open Access
Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma
110
Citations
31
References
2018
Year
Checkpoint InhibitorsHepatocellular CarcinomaMedicineLiver PhysiologyImmunologyPathologyImmune Checkpoint InhibitorLiver CancerAdaptive ResistanceImmunotherapyOncologyTumor Microenvironment
| Year | Citations | |
|---|---|---|
Page 1
Page 1